Sign in
Active, not recruitingPhase 4

Possible Augmentation Of NB-UVB Induced Pigmentation In NSV By Carboxy.

Key facts

Who runs it
Kasr El Aini Hospital
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 4
People taking part
59 people enrolled
Started
15 Sept 2024
Ended
1 Jun 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • NB-UVB alone
  • NB-UVB combined with carboxy
Record updated
1 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Subjects with stable non-segmental vitiligo (≥2 symmetrical patches of diameter less than 2 cm on acral or ≥ 2 symmetrical patches on non-acral sites). Subjects were stable for twelve or more months

Who cannot take part

  • Subjects with unstable vitiligo; Subjects with segmental vitiligo; Pregnant females; Severe anemia (Hb <7 gm/dl); Cardiac/hepatic/renal/respiratory failure; Superficial thrombophlebitis; Subjects with history of skin malignancy or precancerous conditions like Xeroderma pigmentosum; Subjects with other autoimmune disorders; Systemic drugs for vitiligo in the last 3 months

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Patients with stable vitiligo with 2 or more symmetric patches, 2 on acral sites and/or 2 on non acral sites will be recruited and assessed for eligibility for inclusion to receive NB-UVB on the whole body, and carboxytherapy on one randomized side.

The 2 groups in the trial

  • NB-UVBPlacebo, for comparison

    Treatment: NB-UVB alone

  • NB-UVB combined with carboxyExisting treatment, for comparison

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation Of Carboxytherapy As An Adjuvant To Narrowband-Ultraviolet B Phototherapy For The Treatment Of Stable Non-Segmental Vitiligo: A Clinical And Biochemical Study .
Record updated
1 May 2026